A Deep Hypergraph Learning Model for Predicting Antimicrobial Combination Effects Across Bacterial Targets
Farzad MidjaniiD, Amir Hossein RajabiiD, Fateme Zahra KeshtkariD, Mahdi MalekpouriD, Ali JafarizadehiD, Roohallah AlizadehsaniiD, Paweł PławiakiD
Abstract
Antimicrobial resistance (AMR) creates an urgent need for efficient strategies to identify effective antibacterial combinations. Combination therapy, including antimicrobial peptides (AMPs) paired with conventional antibiotics, is a promising approach, but exhaustive experimental screening across drug pairs and bacterial targets is impractical. This study introduces a hybrid GCN-based hypergraph neural network (HGNN) for predicting antimicrobial-agent combination outcomes against bacterial targets. Each antimicrobial-agent-antimicrobial-agent-bacterium triplet is represented as a ternary hyperedge, enabling the model to learn context-dependent interaction patterns. The framework integrates SMILES-derived molecular graph embeddings for antimicrobial agents, including conventional antibiotics and AMPs, with taxonomy-derived bacterial representations. The prediction task was formulated as a three-class classification problem: synergy, antagonism, and non-interaction. The non-interaction class included experimentally verified indifferent records and synthetic presumed non-interaction triplets generated by negative sampling. Model development used drug-pair-grouped splitting, five-fold grouped cross-validation within the training/validation partition, and final evaluation on a held-out test set. On the held-out three-class test set, the selected GCN-based HGNN achieved an accuracy of 0.83, weighted F1-score of 0.84, macro F1-score of 0.80, and ROC-AUC of 0.95. Per-class evaluation showed accuracies of 0.80 for synergy, 0.92 for antagonism, and 0.85 for non-interaction. Pair-type analysis showed strong performance across AMP-AMP, AMP-conventional antibiotic, and conventional antibiotic-conventional antibiotic combinations. These findings suggest that hypergraph-based representation learning can support computational prioritization of antimicrobial combinations for experimental follow-up. Further studies will be needed to improve model interpretability and to perform prospective validation of predicted synergistic combinations.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- GCN-Mamba: Graph Convolutional Network with Mamba for Antibacterial Synergy Prediction
Houlin Su, Yuxi Liang, … Xu Liu·bioRxiv·Mar 12, 2026
- Predicting Antimicrobial Activity for Untested Peptide-Based Drugs Using Collaborative Filtering and Link Prediction
A. Medvedeva, H. Teimouri, A. Kolomeisky·bioRxiv·Nov 16, 2022
- Interpreting Graph Neural Networks for Antibacterial Drug Repurposing against Acinetobacter baumannii
Salvatore Romano, Marco Grassia, … Cristian Taccioli·bioRxiv·Oct 29, 2026
- Bioactivity-Driven Prediction of Antibacterial Synergy Using Machine Learning Models
Hannie Yousefabadi, Mahya Mehrmohamadi·PLoS Computational BiologyPeer-reviewed·Oct 5, 2026
- Predicting antimicrobial class specificity of small molecules using machine learning
Yojana Gadiya, Olga Genilloud, … Andrea Zaliani·Journal of Chemical Information and ModelingPeer-reviewed·Feb 23, 2025
- AntiBP3: A hybrid method for predicting antibacterial peptides against gram-positive/negative/variable bacteria
Nisha Bajiya, Shubham Choudhury, … Gajendra P. S. Raghava·AntibioticsPeer-reviewed·Feb 8, 2024